Jun 05, 2020
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
Jun 04, 2020
INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South Korea
May 11, 2020
INOVIO Reports First Quarter 2020 Financial Results; Provides Business Update
May 11, 2020
Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France
Apr 06, 2020
INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today
Mar 24, 2020
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
Mar 13, 2020
Innovations Abound in the Fight Against COVID-19
Mar 12, 2020
INOVIO Pharmaceuticals Reports 2019 Fourth Quarter and Year-End Financial Results
Feb 04, 2020
Coronavirus Outbreak Sparks Renewed Interest in Combatting Infectious Diseases
Jan 30, 2020
Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China
Jan 29, 2020
VGXI to Manufacture Vaccine Against Novel Coronavirus Under CEPI Funded Collaboration
Jan 15, 2020
Inovio Welcomes Biotech Leader to its Board of Directors
Jan 06, 2020
Inovio Provides Update on Clinical Program Plans for 2020
Nov 25, 2019
Inovio Pharmaceuticals to Present at the 2019 Piper Jaffray 31st Annual Healthcare Conference
Nov 15, 2019
Inovio Pharmaceuticals to Present at the Stifel 2019 Healthcare Conference
Nov 12, 2019
Inovio Pharmaceuticals Reports 2019 Third Quarter Financial Results
Sep 03, 2019
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 08, 2019
Inovio Pharmaceuticals Reports 2019 Second Quarter Financial Results
Jul 25, 2019
Inovio's Positive First-in-Human MERS Vaccine Results Published in The Lancet Infectious Diseases
Jun 10, 2019
Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device